InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Humphrey David Carl, Chief Financial Officer. Officer active across 1 company, notably Ensysce Biosciences, Inc.. Aggregated, 2 filings have been published. Activity tracked since 30 June 2021. The latest transaction was filed on 30 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
50,000 shares0Common StockSEC:0001493152-21-016123
50,000 shares0Common StockSEC:0001493152-21-016123:0
2 of 2 declarations
About Humphrey David Carl
David Carl Humphrey is the Chief Financial Officer at Ensysce Biosciences, Inc. In this role, he oversees the financial operations of the company, which is active in the biopharmaceutical sector. Mr. Humphrey is responsible for financial management and strategy, contributing to the company's growth and sustainability.
